#AstraZeneca #pharmaceuticals #cancerresearch
uk.finance.yahoo.com
AstraZeneca profits jump by 40% amid strong demand for cancer drugs
Drugs giant AstraZeneca has notched up a 40% surge in annual profits and forecast further growth in earnings over the year ahead as it continues to put faith in strong demand for its cancer treatments.